Century Historical Cash Flow

IPSC Stock  USD 0.91  0.03  3.19%   
Analysis of Century Therapeutics cash flow over time is an excellent tool to project Century Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Account Receivables of 43.9 M or End Period Cash Flow of 59.2 M as it is a great indicator of Century Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Century Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Century Therapeutics is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.

About Century Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Century balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Century's non-liquid assets can be easily converted into cash.

Century Therapeutics Cash Flow Chart

At present, Century Therapeutics' End Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 46.2 M, whereas Total Cash From Operating Activities is projected to grow to (75.5 M).

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Capital Expenditures

Capital Expenditures are funds used by Century Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Century Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Century Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Century Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.At present, Century Therapeutics' End Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 46.2 M, whereas Total Cash From Operating Activities is projected to grow to (75.5 M).
 2024 2025 (projected)
Capital Expenditures15.8M22.3M
Change To Inventory70.5M115.1M

Century Therapeutics cash flow statement Correlations

0.560.16-0.68-0.060.440.16-0.430.44-0.24-0.43-0.420.57-0.38-0.1-0.550.57-0.390.40.31-0.39
0.560.02-0.3-0.440.190.020.04-0.210.17-0.160.01-0.14-0.080.40.13-0.14-0.010.010.02-0.01
0.160.02-0.2-0.420.641.0-0.730.490.01-0.45-0.740.45-0.690.34-0.210.46-0.690.620.92-0.68
-0.68-0.3-0.20.06-0.1-0.20.41-0.180.540.260.38-0.340.4-0.080.2-0.340.44-0.46-0.350.45
-0.06-0.44-0.420.06-0.54-0.420.480.170.30.610.5-0.150.7-0.93-0.02-0.150.62-0.61-0.570.61
0.440.190.64-0.1-0.540.64-0.840.71-0.04-0.85-0.860.79-0.820.29-0.670.8-0.790.770.78-0.78
0.160.021.0-0.2-0.420.64-0.730.490.01-0.45-0.740.45-0.690.34-0.210.46-0.690.620.92-0.68
-0.430.04-0.730.410.48-0.84-0.73-0.70.350.871.0-0.790.95-0.350.53-0.80.98-0.97-0.930.97
0.44-0.210.49-0.180.170.710.49-0.70.13-0.54-0.710.79-0.47-0.34-0.70.8-0.530.520.56-0.53
-0.240.170.010.540.3-0.040.010.350.130.290.31-0.40.49-0.250.31-0.390.49-0.53-0.260.5
-0.43-0.16-0.450.260.61-0.85-0.450.87-0.540.290.88-0.690.88-0.470.49-0.690.87-0.88-0.740.87
-0.420.01-0.740.380.5-0.86-0.741.0-0.710.310.88-0.790.95-0.360.53-0.790.97-0.96-0.940.97
0.57-0.140.45-0.34-0.150.790.45-0.790.79-0.4-0.69-0.79-0.72-0.13-0.941.0-0.730.730.64-0.73
-0.38-0.08-0.690.40.7-0.82-0.690.95-0.470.490.880.95-0.72-0.570.46-0.720.99-0.99-0.910.99
-0.10.40.34-0.08-0.930.290.34-0.35-0.34-0.25-0.47-0.36-0.13-0.570.35-0.13-0.510.50.46-0.5
-0.550.13-0.210.2-0.02-0.67-0.210.53-0.70.310.490.53-0.940.460.35-0.930.46-0.47-0.360.46
0.57-0.140.46-0.34-0.150.80.46-0.80.8-0.39-0.69-0.791.0-0.72-0.13-0.93-0.730.740.65-0.73
-0.39-0.01-0.690.440.62-0.79-0.690.98-0.530.490.870.97-0.730.99-0.510.46-0.73-1.0-0.921.0
0.40.010.62-0.46-0.610.770.62-0.970.52-0.53-0.88-0.960.73-0.990.5-0.470.74-1.00.88-1.0
0.310.020.92-0.35-0.570.780.92-0.930.56-0.26-0.74-0.940.64-0.910.46-0.360.65-0.920.88-0.92
-0.39-0.01-0.680.450.61-0.78-0.680.97-0.530.50.870.97-0.730.99-0.50.46-0.731.0-1.0-0.92
Click cells to compare fundamentals

Century Therapeutics Account Relationship Matchups

Century Therapeutics cash flow statement Accounts

202020212022202320242025 (projected)
Capital Expenditures9.8M45.0M30.6M13.7M15.8M22.3M
Total Cash From Operating Activities(41.3M)(89.0M)14.1M(88.3M)(79.5M)(75.5M)
Total Cash From Financing Activities47.7M417.8M27.2M(9.7M)(8.8M)(8.3M)
End Period Cash Flow27.7M58.2M86.2M49.3M56.7M59.2M
Investments(8.2M)(253.4M)17.5M38.3M44.0M46.2M
Change In Cash(16.3M)30.4M28.1M(36.9M)(33.2M)(31.6M)
Stock Based Compensation876K4.7M10.7M14.6M16.8M17.7M
Free Cash Flow(51.1M)(134.0M)(16.6M)(102.1M)(91.9M)(96.5M)
Change In Working Capital4.9M(2.8M)123.9M9.4M10.8M10.2M
Begin Period Cash Flow44.1M27.7M58.2M86.2M99.2M54.5M
Other Cashflows From Financing Activities38.0M196.2M(13.1M)61.1M55.0M57.1M
Depreciation1.4M3.7M8.4M13.0M15.0M15.8M
Other Non Cash Items444K1.2M1.9M11.3M10.2M9.6M
Issuance Of Capital Stock159.7M381.2M27.2M967K870.3K826.8K
Net Income(53.6M)(95.8M)(130.9M)(136.7M)(157.2M)(165.0M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Century Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Century Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Century Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Century Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Century Therapeutics. If investors know Century will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Century Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.84)
Revenue Per Share
0.037
Quarterly Revenue Growth
4.345
Return On Assets
(0.21)
Return On Equity
(0.63)
The market value of Century Therapeutics is measured differently than its book value, which is the value of Century that is recorded on the company's balance sheet. Investors also form their own opinion of Century Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Century Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Century Therapeutics' market value can be influenced by many factors that don't directly affect Century Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Century Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.